Lumexa Imaging Holdings, Inc. Common Stock
LMRI
NASDAQ Global Select- -
USD
- -
- -
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Caitlin Zulla
- Sector
- Healthcare
- Industry
- Medical - Devices
- Address
- 4200 Six Forks Road Raleigh NC United States of America 27609
- IPO Date
- Dec 11, 2025
- CIK
- 0002071288
- Website
- lumexaimaging.com
- Similar Companies
- Business
- Lumexa Imaging Holdings, Inc. (Nasdaq: LMRI) operates the second-largest outpatient imaging center network in the United States, providing diagnostic imaging services through 184 centers across 13 states, including 85 joint ventures with health systems as of September 30, 2025. The company offers advanced imaging modalities such as magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET) scans; basic diagnostic services including X-rays, ultrasounds, and mammograms; and operates via wholly owned centers, variable interest entities, and joint ventures, generating management fees from unconsolidated affiliates. Lumexa Imaging utilizes a scalable integrated technology platform with third-party AI solutions to enhance efficiency and clinical quality, serving a diversified referral network of approximately 100,000 physicians across 29,000 practices, with centers featuring convenient retail settings and extended hours. Founded in 2018 through a partnership between Charlotte Radiology and private equity firm Welsh, Carson, Anderson & Stowe, Lumexa Imaging is headquartered in Raleigh, North Carolina. The company has rapidly expanded from 20 centers in 2018 to its current footprint via 20 acquisitions and 41 de novo openings, targeting high-growth metropolitan areas with favorable demographics. It employs over 5,000 team members and a network of more than 1,000 subspecialized radiologists, performing over 4 million outpatient studies annually. In recent developments, Lumexa Imaging completed its initial public offering on December 10, 2025, pricing 25 million shares at $18.50 to raise $462.5 million, with proceeds primarily allocated to repay a portion of its $1.2 billion term loan debt. Effective July 8, 2025, its affiliate US Radiology Specialists Holdings, LLC rebranded to Lumexa Imaging Equity Holdco, LLC, aligning with the company's unified identity. These moves support ongoing growth in the diagnostic imaging sector, where 58% of consolidated revenue derives from commercial payors.